Inge Marie Svane, Prof., M.D.
Study Director, CCIT-DK, Depth of Oncology, Herlev Hospital · Study Director, National Center for Cancer Immune Therapy, Dept. of Oncology, Hospital Herlev · Center for Cancer Immune Therapy, Depth of Hematology/Oncology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, DK-2730
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Inge Marie Svane, Prof., M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:22 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06204991 · To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic MelanomaInge Marie Svane · recruiting · Melanoma Stage III, Melanoma Stage IV, Melanoma · study director
- Ph1/Ph2NCT04611126 · T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian CancerInge Marie Svane · terminated · Metastatic Ovarian Cancer, Metastatic Fallopian Tube Cancer, Peritoneal Cancer · study director
- Ph1/Ph2NCT03287674 · TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian CancerInge Marie Svane · completed · Metastatic Ovarian Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.